Page last updated: 2024-09-05

sb 203580 and Proteinuria

sb 203580 has been researched along with Proteinuria in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, H; Jiang, D; Jin, N; Wang, Q; Zhang, X; Zhu, K1

Other Studies

1 other study(ies) available for sb 203580 and Proteinuria

ArticleYear
The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus.
    International immunopharmacology, 2011, Volume: 11, Issue:9

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Complement C3; Creatinine; Female; Hepatocytes; Imidazoles; Immunoglobulins; Kidney; Kidney Diseases; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Proteinuria; Pyridines; Spleen

2011